Article ID Journal Published Year Pages File Type
9601007 Clinical Oncology 2005 6 Pages PDF
Abstract
In this study, serial neurologic assessment of patient symptoms and signs seemed to be a better indicator of a possible glutamine effect than sensory- or motor-nerve-conduction studies. Prospective randomised trials are needed to clarify the effect of glutamine on paclitaxel and other types of chemotherapy-induced neuropathy.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , ,